| HS Code | 451005 |
| Chemical Name | ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride |
| Molecular Formula | C31H32N8O3·HCl |
| Molecular Weight | 603.1 g/mol (free base: 569.6 g/mol) |
| Cas Number | 1616754-77-6 |
| Appearance | white to off-white solid |
| Solubility | soluble in DMSO, moderately soluble in water |
| Storage Conditions | store at -20°C, desiccated |
| Purity | ≥98% (HPLC) |
| Synonyms | GSK3326595 hydrochloride, Iadademstat intermediate |
| Application | used as a PRMT5 inhibitor in biochemical and cell-based assays |
| Smiles | CCOC(=O)CCCN(C(=O)c1ccc2nc(C)n(-c3ccccn3)c2c1)Cc4ccc(cc4)C(=N)N.Cl |
| Inchi Key | MAUCGIYYVJWQFH-UHFFFAOYSA-N |
| Target | protein arginine methyltransferase 5 (PRMT5) |
| Bioactivity | demonstrates potent inhibitory activity against PRMT5 |
As an accredited ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging consists of a 100 mg amber glass vial, sealed with a screw cap, labeled with product name, concentration, and hazard information. |
| Container Loading (20′ FCL) | 20′ FCL allows bulk transport of the chemical in secure, sealed containers, ensuring safe and efficient international shipping and handling. |
| Shipping | This chemical, **ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride**, ships in tightly sealed containers, protected from moisture and light, and according to all relevant hazardous material regulations. Packaging ensures chemical stability, with proper labeling and documentation for safe handling and compliant international or domestic transit. |
| Storage | Store **ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride** in a tightly sealed container, protected from light and moisture, at 2–8 °C (refrigerated conditions). Handle in a well-ventilated area, using appropriate personal protective equipment. Keep away from incompatible substances, such as strong acids, bases, and oxidizing agents. Dispose of according to local regulations. |
| Shelf Life | Shelf life: Stable for 2 years when stored at -20°C, protected from light and moisture, and kept tightly sealed. |
As the manufacturer, we supply ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride for various high-value downstream sectors, each requiring precise compliance, technical processing, and targeted end-use transformation. The following industry applications reflect actual adoption in regulated environments, where integration into the formulated system enables downstream manufacturers to achieve reliable quality and specific product performance.
This compound serves as a key building block for advanced oncology active pharmaceutical ingredient (API) synthesis, particularly in the research and pre-commercial production of next-generation kinase inhibitor drug candidates. Process chemists incorporate this intermediate during late-stage synthetic steps, focusing on purity, reaction yield, and side product control to meet investigational drug quality requirements. Downstream pharmaceutical manufacturers rely on the precise integration of this molecule to establish consistent batch reproducibility and data traceability, conforming to global clinical development standards.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Downstream diagnostic developers utilize this specialty compound as a structural core for the construction of molecular probes, specifically in the area of fluorescence-based imaging and detection systems targeting abnormal protein activity in malignant tissue. The high specificity of the benzimidazole core enables reliable probe-target interaction. Process engineers focus on manufacturing repeatability, solvent residue control, and labeling efficiency in the final probe product to ensure compliance with stringent diagnostic reagent regulations.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Leading biopharmaceutical QA/QC labs employ this compound as a certified analytical standard for validating HPLC and LC-MS analytic methods during process validation, release testing, and impurity profiling of structurally similar therapeutic molecules. Its consistent spectral and chromatographic properties enable labs to establish retention time, purity benchmarks, and quantitation procedures for regulated environments.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
CROs, academic institutes, and pharmaceutical discovery teams deploy this molecule for preclinical research to investigate biological pathway modulation, cellular uptake, and target engagement studies. Integrated into high-content screening and in vitro pharmacology workflows, researchers require consistent material quality, traceable batch documentation, and ready-to-use salt form to standardize experimental reproducibility. Our quality management system maintains full origin-to-delivery transparency required by funded research programs and collaborative consortia.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8618005193850
Email: sales8@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every so often, our industry witnesses a leap in chemical technology that sets a new standard for what precision and reliability look like. Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride represents one of those moments. This is not just another molecule to ship out of a vast catalogue. Years of directed research shaped it, guided by feedback from pharmaceutical partners who demand more than a purity certificate and a shipping carton.
On our factory floor, the production line bears little resemblance to the anonymous bulk reactors churning out generic intermediates. Small batch control, precise monitoring, and documented traceability drive every step. We institute regular sampling with online HPLC checks, in addition to LC-MS analysis for every batch. You cannot shortcut specificity—each synthesis stage must deliver the right compound, with side products driven to the background, impurities quantified, and protocols updated as soon as site specialists identify any parameter drift.
With this molecule, there’s no room for guesswork. Our years working side by side with medicinal chemists, analytical teams, and formulation scientists have taught us where the problems lie. This is not a piecemeal operation; it is an iterative process. Chemical development has to respect the needs of lab-scale creativity and the rigors of scale-up. Scaling this compound from the gram scale to multi-kilogram runs introduced challenges with solubility, crystallization rate, and salt formation. The process is never finished. Even today, we look at every single batch data sheet, seeking either improvements in yield or a new way to capture trace solvent residues.
At first glance, the IUPAC name paints a daunting structure, but chemists see the story within the scaffold. This compound brings together linking groups famous for bioactivity, combining a benzimidazole core with a guanidine-bearing phenyl ring, a pyridyl fragment, and a carboxamide bridge. This arrangement offers versatility: researchers target it for kinase modulation, receptor binding, and assays exploring signal transduction pathways.
We have watched interest grow around this scaffold, not just due to its complexity but its functionality. The addition of a propanoate ester moiety extends its solubility profile, supporting multiple formulation strategies. The hydrochloride counterion brings stability in storage and consistency in analytical readings. These design features arise from practical needs on the bench. During early collaborations, clients outlined dissolution problems with open-chain analogues. We responded with pilot studies modifying the salt form and confirmed that the hydrochloride delivers consistent, rapid solution in standard assay buffers.
In the lab notebook or in our ERP system, the model code for this molecule reads as one of our flagship specialty intermediates, tied to a sequence of analytical records, quality releases, and shipment histories. Over time, specifications have evolved. The typical purity, measured by HPLC, sits above 98%. Water content, checked by KF titration, remains under 1%. Bulk density and particle size distribution are regularly documented, since many customers request technical grade, research grade, and pilot batch material. Routinely, we field questions about trace metal content, especially in projects destined for pharmaceutical R&D. We set our acceptance criteria by referencing standards used in regulated environments, mirroring the expectations of clients developing next-generation small molecules.
Every bottle leaving our warehouse carries a series of batch numbers, COAs, and a full retention sample in climate-controlled storage. Because we work directly with research groups pushing for clinical candidates, the margin for error narrows sharply. If the NMR signals don’t line up with reference spectra, we map out the discrepancy. If a client requests reanalysis, our analytical team responds within hours. This is not just pride—it is the foundation for trust.
Flexible batch size and customization factor into every discussion we have with synthetic chemists and R&D teams. Early-stage projects require only small bottles, which we secure with tamper-evident seals and dual barcoding. As programs mature into lead series or preclinical development, order volumes increase to several kilos. Our supply chain team manages stock to buffer against procurement spikes, and we validate packaging integrity at multiple checkpoints to reduce risk during international shipping. With every client, whether an academic group, a biotech startup, or a global pharmaceutical powerhouse, we establish open channels and rapid turnaround times on reorders.
Chemists are seldom interested in standardized containers or set increments. They want a level of responsiveness to evolving timelines—project delays, new pivots in SAR, or sudden breakthroughs. We carry additional inventory when demand surges. We document temperature and humidity conditions for every shipment, tracking product stability over months using ICH protocols. If the data hint at a susceptibility to hydrolysis or polymorph conversion, we let customers know immediately, not after a problem arises in the assay.
This is a specialty molecule in a world filled with similar names and numbers. Side-by-side with more standard benzimidazole derivatives, its distinguishing features stand out. Many compounds offer basic aromatic scaffolds, but few deliver the guanidine functionality so cleanly integrated into the phenyl ring, nor the rigorously optimized salt form. We frequently receive sample requests from scientists already frustrated by reference material from online resellers or bulk chemical warehouses. They have learned that price counts for little if the product fails in solubility, forms ambiguous tars, or introduces unknown signals in LC-MS chromatograms.
We run in-house head-to-head comparisons and share the raw data. For this compound, batch repeatability and impurity profiling define the difference. Our investment in controlled atmospheres for synthesis, strict solvent use policies, and a closed transfer system during purification minimize the risk of contamination. This not only improves the isolation of the desired product, but also simplifies the analytical workup for clients. We can provide impurity profiles with named reference standards and quantify them below 0.1%, where others either guess or omit the information entirely.
Physical consistency is another differentiator. One batch from an unverified source can bring more frustration than utility: differing polymorph profiles, variable flow characteristics, or unpredictable hygroscopicity. Our plant runs physical checks at every packaging stage. Manual sieving, automated particle counters, and stability chambers provide hard data, not just stock photos and templated paperwork.
Because our facility never cross-manufactures this product with similarly structured analogues in the same synthesis vessel, there is no risk of cross contamination with adjacent intermediates. For customers working under cGMP development, this commitment offers peace of mind—clear chain of custody, no ambiguity, tight documentation.
End users range from academic researchers mapping structure-activity relationships to pharma groups designing new molecular entities with targeted function. Early-stage data now point to this molecule’s value in kinase assay studies and mechanistic cell signaling investigations. Collaborators have shared feedback about compound stability in DMSO, rapid bioassay preparation, and clean readouts in screening campaigns. As a manufacturer, these stories shape our pursuit of even tighter tolerance in specs and more reliable sourcing.
We spend significant effort consulting with downstream users about assay troubleshooting. Problems rarely trace to the synthetic route alone. Residual solvent, salt stoichiometry, or even batch recirculation sometimes complicate downstream handling. By maintaining dialogue long after the order leaves our warehouse, we help resolve technical issues quickly—whether it means sending fresh analytical data or reworking a purification step for a follow-up order. Every case of material incompatibility becomes a learning tool for the next batch. Over time, these incremental changes raise the bar for every kilo produced.
Many clients operate under regulatory constraints for preclinical or early-phase research. Our main facility meets all documentation requirements and holds certifications judged by regular third-party audits. Analytical records are archived, not just for compliance but to help our partners fulfill their obligations without last-minute surprises during scale-up or submission.
Making a sophisticated compound at this level involves more than rote repetition. Batch failures sometimes occur, despite detailed SOPs and automated controls. Solubility fluctuations, unexpected polymorphs, or inconsistent acid-to-base ratios in the salt form turn up, particularly during times of seasonally variable humidity or raw material shortages. Our process engineers monitor every deviation and work closely with suppliers. By qualifying every lot and insisting on written certificates for key intermediates, we reduce risk.
Real progress comes from sharing what works. Effective process enhancements, such as intermediate holding tanks to smooth flow rates during precipitation or double-staging our purification columns, have incrementally improved both consistency and yield. Where many organizations would conceal batch setbacks and quietly dispose of off-specification material, we log everything: trace impurity levels, color changes, filtration rates. This culture of transparency helps our team solve problems together and adapt for the next production cycle.
One persistent challenge is environmental safety. Byproducts and moderate quantities of organic solvents pose a real risk to worker safety and compliance. We operate closed systems that capture volatile organic compounds and collect them for safe disposal. On a practical level, this protects not only our staff but also the partners who rely on us for green supply chains. Waste minimization plans are part of our manufacturing philosophy, and all operators undergo regular safety and sustainability training.
Research chemicals such as ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride seldom receive mainstream attention, but for those driving molecular innovation, the margin for quality narrows. Each run on our production line is validated, documented, and reviewed to ensure total traceability.
Standing behind this product means keeping lines of communication open with researchers, fielding questions rapidly, and iterating specifications based on real usage experience. New partnerships emerge every year, with colleagues challenging us to raise standards, adopt improved analytical techniques, or consider new solvent systems or salt forms. Our technical service team regularly shares crystallographic data, batch-specific impurity analysis, and process optimization suggestions with clients, welcoming dialogue and collaboration. The work never stops at basic supply.
Open feedback loops keep our quality system resilient. Each adverse report, delay, or process failure feeds directly into regular shop floor reviews. Instead of blaming machine downtime or blaming unexpected raw material composition, we focus on finding actionable solutions. Operators, chemists, and QC specialists meet regularly to revise protocols, with hard targets for reducing deviations and batch-to-batch variability.
Long-term production ensures that each batch meets not only chemical but also legal requirements. Our document archives support customs clearance, import licensing, and regulatory audits. We share full MSDS sheets, adhere to REACH, and supply data on potential genotoxic impurities on request. Material hygiene sits at the core of our operation—not just to satisfy paperwork, but because we have seen firsthand how supply chain gaps can derail high-value projects.
Where stability data raise new questions, we launch root-cause investigations and amend packaging or storage recommendations accordingly. Product recalls are rare, but when they are necessary, we rely on our well-documented trace-and-recall system.
Customer trust builds slowly, through the consistency of every order and the integrity of every record. Regulatory expectations grow each year, with new standards on trace metals, nitrosamines, and biological contamination. By staying ahead of these changes, we help our partners move their discoveries through the pipeline without unneeded roadblocks or compliance setbacks.
The pressure to speed up pharmaceutical innovation only grows, and niche compounds see far more rapid movement from research to marketable application. This drives internal investment in automation, digital batch records, and rapid screening for physical and chemical attributes. Automation helps eliminate human variability, but manual oversight still matters in resolving ambiguous chromatograms and spectral assignments.
We track market shifts alongside scientific journals, regularly updating our processes to reflect the latest published knowledge and client requests. Our R&D chemists participate in conferences, webinars, and working groups to stay ahead of both technical and regulatory trends.
Client needs also drive change. As targeted therapies and diagnostics grow more complex, so too must ingredient profiles. Products can outgrow their original utility, so our team stands ready to refine, rework, and even scale up based on new data from clinical or laboratory partners. By listening and adapting, we keep our clients' projects running smoothly—even as their needs change.
From the vantage point of a manufacturer, ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride represents the convergence of practical chemistry and relentless process refinement. Day after day, the core staff measure, synthesize, purify, test, and package, drawing on hard-won experience to meet the expectations of the highest-tier research customers. The value of this product lies in its reliability—not just in yield, but in the trust that every shipment matches the claims.
With ongoing innovation, collaboration, and honest feedback, advanced molecules like this influence what medicine, biotechnology, and diagnostics can achieve. As a manufacturer anchored in facts and open to constantly learning from experience, we see each complex intermediate as an opportunity—not just to meet demand, but to shape something lasting for science and industry.